30
Informaciones
Psiquiátricas
2015 - n.º 220
Javier Olivera Pueyo / María José Val Clau / Cristina Hermoso Contreras / Carmelo Pelegrín Valero
15. Seitz DP, Gill SS, Herrmann N, Brisbin
S, Rapoport MJ, Rines J et al. Pharma-
cological treatments for neuropsychia-
tric symptoms of dementia in long-term
care: a systematic review. Int Psychoge-
riatrics. 2013; 25 (2): 185-203.
16. American Psychiatric Association (APA).
Resource Document on the Use of Anti-
psychotic Medications to Treat Behavioral
Distrubances in Persons with Dementia.
APA Council on Geriatric Psychiatry. 2014.
17. Press D, Alexander M. Management of
neuropsychiatric symptoms of demencia.
UpToDate. 2014: 1-22.
18. Lonergan E, Luxenberg J, Colford J.
Haloperidol para la agitación en la de-
mencia (Revisión Cochrane traducida).
En: La Biblioteca Cochrane Plus, 2008
Número 4. Oxford: Update Software Ltd.
Disponible en:
-
ware.com.
19. Kales HC, Kim HM, Zivin K, Valenstein
M, Seyfried LS, Chiang C et al. Risk of
mortality among individual antipsychia-
tics in patients with dementia. Am J
Psychiatry. 2012; 169: 71-79.
20. Allain H, Dautzenberg PH, Maurer K,
Schuck S, Bonhomme D, Gérard D. Dou-
ble blind study of tiapride versus ha-
loperidol and placebo in agitation and
aggressiveness in elderly patients with
cognitive impairment. Psychopharmaco-
logy. 2000. 148(4): 361-6.
21. Robert PH, Allain H. Clinical manage-
ment of agitation in the elderly with
tiapride. Eur Psychiatry. 2001; 16 (Suppl
1): 42s-47s.
22. Agencia Española de Medicamentos y
Productos Sanitarios (AEMPS). Revi-
sión de la seguridad en el tratamiento
de los síntomas psicóticos asociados a
demencia. Comisión Asesora del Comité
de Seguridad de Medicamentos. Madrid.
2007.
23. Lee PE, Gill SS, Freedman M, Bronskill
SE, Hillmer MP, Rochon PA. Atypical an-
tipsychotics drugs in the treatment of
behavioural and psychological sympto-
mos of dementia: systematic review.
BMJ. 2004; 10; 329 (7457):75.
24. Baskys A. Lewy body dementia: the lit-
mus test for neuoleptic sensitivity and
extrapyramidal symptoms. J Clin Psy-
chiatry. 2004; 65. Suppl 11: 16-22.
25. Campanelli CM, American Geriatrics So-
ciety Updated Beers Criteria for Poten-
tially Inappropriate Medication Use in
Older Adults. The American Geriatrics
Society 2012 Beers Criteria Update Ex-
pert Panel. J Am Geriatr Soc (JAGS).
2012; 60(4): 616-631.
26. GAO (United States Government Accoun-
tability Office). A Report to Congressio-
nal Requesters. Antipsychotic Drugs and
Older Adults. HHS has initiatives to re-
duce use among older adults in nursing
homes, but should expand efforts to
other settings. 2015.
27. Banerjee S. The use of antipsychotics
medication for people with dementia:
Time for action. A report for Minister of
State for Care Services. An independent
report commissioned and funded by De-
partment of Health. 2009.
